Merck & Co. Inc. closed 29.03% below its 52-week high of $134.63, which the company reached on June 25th.

Germany's Merck KGaA is betting on partnerships to boost its biopharma business. Speaking with Bloomberg TV on the sidelines ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price target of ...

Merck & Co's Covid-19 antivirals are getting ... companies including Henan Genuine Biotech Co., Simcere Pharmaceutical Group Ltd. and Shanghai Junshi Biosciences Co. A spokesperson for Merck ...

NEW YORK, NY - MAY 14: The MetLife corporate logo sits at the top of their building ... the policyholder account balances. The company’s group benefits business was a weak performer over the ...

The terrorist group is responsible for some of the bloodiest attacks in Pakistan, including on churches, schools and the shooting of Malala Yousafzai, who survived the 2012 attack after she was ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of data from the Phase 2 waveLINE-007 trial ...